Literature DB >> 22046197

Immunomodulation by vitamin D: implications for TB.

Rene F Chun1, John S Adams, Martin Hewison.   

Abstract

TB remains a major cause of mortality throughout the world. Low vitamin D status has been linked to increased risk of TB and other immune disorders. These observations suggest a role for vitamin D as a modulator of normal human immune function. This article will detail the cellular and molecular mechanisms by which vitamin D regulates the immune system and how vitamin D insufficiency may lead to immune dysregulation. The importance of vitamin D bioavailability as a mechanism for defining the immunomodulatory actions of vitamin D and its impact on TB will also be discussed. The overall aim will be to provide a fresh perspective on the potential benefits of vitamin D supplementation in the prevention and treatment of TB.

Entities:  

Keywords:  CYP24A1; CYP27B1; TB; Toll-like receptor; cathelicidin; defensins; monocyte; neutrophil; vitamin D; vitamin D receptor

Mesh:

Substances:

Year:  2011        PMID: 22046197      PMCID: PMC3201845          DOI: 10.1586/ecp.11.41

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  117 in total

1.  Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis.

Authors:  Roni Grad
Journal:  Pharm Hist       Date:  2004

Review 2.  Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.

Authors:  Padmini Salgame
Journal:  Curr Opin Immunol       Date:  2005-08       Impact factor: 7.486

3.  Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages.

Authors:  U E Schaible; S Sturgill-Koszycki; P H Schlesinger; D G Russell
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

4.  An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3.

Authors:  A Nykjaer; D Dragun; D Walther; H Vorum; C Jacobsen; J Herz; F Melsen; E I Christensen; T E Willnow
Journal:  Cell       Date:  1999-02-19       Impact factor: 41.582

5.  Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages.

Authors:  Maximiliano G Gutierrez; Sharon S Master; Sudha B Singh; Gregory A Taylor; Maria I Colombo; Vojo Deretic
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

Review 6.  Overview of general physiologic features and functions of vitamin D.

Authors:  Hector F DeLuca
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

7.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.

Authors:  Adrian F Gombart; Niels Borregaard; H Phillip Koeffler
Journal:  FASEB J       Date:  2005-07       Impact factor: 5.191

8.  Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London.

Authors:  A Ustianowski; R Shaffer; S Collin; R J Wilkinson; R N Davidson
Journal:  J Infect       Date:  2005-06       Impact factor: 6.072

9.  Effects of cytokines on mycobacterial phagosome maturation.

Authors:  L E Via; R A Fratti; M McFalone; E Pagan-Ramos; D Deretic; V Deretic
Journal:  J Cell Sci       Date:  1998-04       Impact factor: 5.285

10.  1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line.

Authors:  K A Rockett; R Brookes; I Udalova; V Vidal; A V Hill; D Kwiatkowski
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more
  14 in total

1.  Immunology: Vitamins prime immunity.

Authors:  Wei-Jen Chua; Ted H Hansen
Journal:  Nature       Date:  2012-11-29       Impact factor: 49.962

Review 2.  How important is vitamin D in preventing infections?

Authors:  P O Lang; N Samaras; D Samaras; R Aspinall
Journal:  Osteoporos Int       Date:  2012-11-17       Impact factor: 4.507

3.  Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles.

Authors:  Leon J Khoza; Pradeep Kumar; Admire Dube; Patrick H Demana; Yahya E Choonara
Journal:  Int J Pharm       Date:  2022-06-06       Impact factor: 6.510

Review 4.  Novel adjunctive therapies for the treatment of tuberculosis.

Authors:  A A Ordonez; M Maiga; S Gupta; E A Weinstein; W R Bishai; S K Jain
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

5.  Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis.

Authors:  Yunfei Zhan; Ling Jiang
Journal:  Exp Ther Med       Date:  2014-10-31       Impact factor: 2.447

6.  Adult pulmonary tuberculosis as a pathological manifestation of hyperactive antimycobacterial immune response.

Authors:  Pawan Kumar
Journal:  Clin Transl Med       Date:  2016-09-21

7.  The impact of rickets on growth and morbidity during recovery among children with complicated severe acute malnutrition in Kenya: A cohort study.

Authors:  Moses M Ngari; Johnstone Thitiri; Laura Mwalekwa; Molline Timbwa; Per Ole Iversen; Greg W Fegan; James A Berkley
Journal:  Matern Child Nutr       Date:  2017-11-27       Impact factor: 3.092

Review 8.  Host-Directed Therapeutic Strategies for Tuberculosis.

Authors:  Afsal Kolloli; Selvakumar Subbian
Journal:  Front Med (Lausanne)       Date:  2017-10-18

Review 9.  '"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection.

Authors:  M Alexandra Lake; Lyn R Ambrose; Marc C I Lipman; David M Lowe
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

Review 10.  Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment.

Authors:  Aysha Arshad; Sujay Dayal; Raj Gadhe; Ajinkya Mawley; Kevin Shin; Daniel Tellez; Phong Phan; Vishwanath Venketaraman
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.